Effects of a Combination of Polynucleotide and Hyaluronic Acid for Treating Osteoarthritis

Int J Mol Sci. 2024 Jan 30;25(3):1714. doi: 10.3390/ijms25031714.

Abstract

Knee osteoarthritis (OA), an age-related degenerative disease characterized by severe pain and disability, is treated using polynucleotides (PNs) and hyaluronic acid (HA). The intra-articular (IA) injection of HA has been studied extensively in both animal models and in humans; however, the efficacy and mechanisms of action remain unclear. In addition, there has been a paucity of research regarding the use of PN alone or in combination with HA in OA. To investigate the effect of the combined injection of PN and HA in vivo, pathological and behavioral changes were assessed in an OA model. Anterior cruciate ligament transection and medial meniscectomy were performed in Sprague-Dawley rats to create the OA animal model. The locomotor activity improved following PNHA injection, while the OARSI grade improved in the medial tibia and femur. In mild OA, TNFα levels decreased histologically in the PN, HA, and PNHA groups but only the PNHA group showed behavioral improvement in terms of distance. In conclusion, PNHA exhibited anti-inflammatory effects during OA progression and improved locomotor activity regardless of the OARSI grade.

Keywords: anterior cruciate ligament transection; hyaluronic acid; knee OA; medial meniscectomy; polynucleotide.

MeSH terms

  • Animals
  • Anterior Cruciate Ligament / surgery
  • Humans
  • Hyaluronic Acid* / pharmacology
  • Injections, Intra-Articular
  • Osteoarthritis, Knee* / drug therapy
  • Polynucleotides / pharmacology
  • Polynucleotides / therapeutic use
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Hyaluronic Acid
  • Polynucleotides